These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics. Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347 [TBL] [Abstract][Full Text] [Related]
24. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Levy R Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513 [No Abstract] [Full Text] [Related]
25. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598 [TBL] [Abstract][Full Text] [Related]
26. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study. Grossmann WM; Standl A; May U; van Laak HH; Hirche H Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328 [TBL] [Abstract][Full Text] [Related]
27. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia]. Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091 [No Abstract] [Full Text] [Related]
28. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507 [No Abstract] [Full Text] [Related]
29. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520 [No Abstract] [Full Text] [Related]
30. Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease. Levy R; Little A; Chuaqui P; Reith M Lancet; 1983 Apr; 1(8331):987-8. PubMed ID: 6132292 [No Abstract] [Full Text] [Related]
31. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses. Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM Arch Gen Psychiatry; 1986 Aug; 43(8):727-32. PubMed ID: 3729666 [TBL] [Abstract][Full Text] [Related]
32. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. Götestam KG; Ljunghall S; Olsson B Acta Psychiatr Scand Suppl; 1981; 294():46-53. PubMed ID: 7041519 [TBL] [Abstract][Full Text] [Related]
33. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT). Fünfgeld EW; Baggen M; Nedwidek P; Richstein B; Mistlberger G Prog Clin Biol Res; 1989; 317():1235-46. PubMed ID: 2690093 [TBL] [Abstract][Full Text] [Related]
34. Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Whitehouse PJ; Orgogozo JM; Becker RE; Gauthier S; Pontecorvo M; Erzigkeit H; Rogers S; Mohs RC; Bodick N; Bruno G; Dal-Bianco P Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():56-60. PubMed ID: 9305519 [No Abstract] [Full Text] [Related]
35. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings]. Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644 [No Abstract] [Full Text] [Related]
36. Treatment of the elderly suffering from psychosis and dementia. Sunderland T J Clin Psychiatry; 1996; 57 Suppl 9():53-6. PubMed ID: 8823351 [TBL] [Abstract][Full Text] [Related]
37. Double blind study of lecithin in patients with Alzheimer's disease. Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239 [No Abstract] [Full Text] [Related]
38. Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia. Christie JE; Shering A; Ferguson J; Glen AI Br J Psychiatry; 1981 Jan; 138():46-50. PubMed ID: 7023592 [TBL] [Abstract][Full Text] [Related]
39. Lecithin in the treatment of Alzheimer's disease. Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143 [No Abstract] [Full Text] [Related]